化瘀通络中药对肾衰大鼠肾组织CTGF蛋白表达的实验研究  被引量:1

Effects of Chinese Herbs with Functions of Removing Blood Stasis and Channel Obstruction on Expression of CTGF Protein in Renal Tissues of Rats with Renal Failure

在线阅读下载全文

作  者:尹智炜[1] 陈志强[1] 丁奇峰[1] 张再康[1] 张芬芳[1] 杨阳[1] 

机构地区:[1]河北医科大学中西医结合研究所,河北石家庄050017

出  处:《中国中医基础医学杂志》2007年第5期362-364,共3页JOURNAL OF BASIC CHINESE MEDICINE

基  金:河北省博士资金项目(03547015D)

摘  要:目的:采用蛋白质印迹法(Western Blot)检测化瘀通络中药肾络通对5/6肾切除肾衰大鼠残余肾结缔组织生长因子(CTGF)蛋白表达的影响。方法:5/6肾切除制备肾衰大鼠模型,随机分为假手术组、模型组、肾络通组和缬沙坦组,分别灌胃给药16周取材,应用Western Blot法检测肾组织CTGF蛋白的表达。结果:模型组与假手术相比,CTGF蛋白的表达明显增高;肾络通组CTGF蛋白表达较模型组显著降低。结论:肾络通可使慢性进展性纤维化肾组织CTGF蛋白表达下调,延缓5/6肾切除肾衰大鼠的病程进展,提示以CTGF为切入点,运用不同的有效中药组方对其加以研究,将为肾纤维化防治提供新的思路。Objective: To Analysis of CTGF's protein in rats' remnant kidney of 5/6 nephrectomy induced chronic renal failure (CRF) with treatment of traditional Chinese medicine of disperse blood stasis and dredge collateral Shen Luo Tong by Western Blot. Method: The CRF model of rat made through 5/6 nephrectomy. The rats were divided into four groups including Sham group, Model group, Shen Luo Tong group and Valsartan group. After 16-week intragastric administration, the expression of CTGF' s protein in nephridial tissue was detected by Western Blot. Results: Compare with Sham group, the expression of CTGF' s protein of Model group was increased obviously; While compare with Model group, the expression of CTGF' s protein of Shen Luo Tong and Valsartan group was decreased obviously. Conclusion: Shen Luo Tong maybe play an great role in delaying the proceeding of CRF by down-regulation the expression of CTGF' s protein. It indicated that study of down-regulation the expression of CTGF with treatment of different traditional Chinese medicine compound recipe will provide new methods for the prevention and cure of renal fibrosis.

关 键 词:化瘀通络 肾络通 结缔组织生长因子 Western BLOT 

分 类 号:R285.5[医药卫生—中药学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象